D.E. Shaw & Co
OSIR

D.E. Shaw & Co’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

D.E. Shaw & Co’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-140,978
Closed -$692K – 3820
2016
Q4 		$692K Buy
140,978
+32,808
+30% +$168K ﹤0.01% 2678
2016
Q3 		$537K Sell
108,170
-3,388
-3% -$17.3K ﹤0.01% 2760
2016
Q2 		$568K Buy
111,558
+14,937
+15% +$80.4K ﹤0.01% 2740
2016
Q1 		$552K Buy
96,621
+77,465
+404% +$541K ﹤0.01% 2737
2015
Q4 		$199K Sell
19,156
-50,339
-72% -$683K ﹤0.01% 3563
2015
Q3 		$1.28M Sell
69,495
-54,608
-44% -$1.05M ﹤0.01% 2425
2015
Q2 		$2.42M Buy
124,103
+57,499
+86% +$1.02M ﹤0.01% 2042
2015
Q1 		$1.17M Buy
66,604
+52,818
+383% +$887K ﹤0.01% 2443
2014
Q4 		$220K Buy
+13,786
New +$185K ﹤0.01% 3774
2014
Q3 		– Sell
-10,653
Closed -$166K – 4706
2014
Q2 		$166K Buy
+10,653
New +$157K ﹤0.01% 4028
2014
Q1 		– Sell
-10,418
Closed -$168K – 4991
2013
Q4 		$168K Sell
10,418
-9,448
-48% -$151K ﹤0.01% 4306
2013
Q3 		$331K Buy
19,866
+657
+3% +$9.71K ﹤0.01% 3853
2013
Q2 		$193K Buy
+19,209
New +$202K ﹤0.01% 3769

Other funds holding OSIR

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

D.E. Shaw & Co's OSIR Position: Q1 2017 in Review

D.E. Shaw & Co sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2017, closing a stake of 140,978 shares — an estimated $692K sold.

D.E. Shaw & Co first reported a position in OSIR in Q2 2013 and held it in 13 quarters. The position peaked at $2.42M in Q2 2015. 11 funds tracked by Wall St. Rank hold OSIR as of Q1 2017.

  • D.E. Shaw & Co reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 140,978 Osiris Therapeutics, Inc. Common Stock shares in Q1 2017, an estimated $692K.
  • D.E. Shaw & Co first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • D.E. Shaw & Co's Osiris Therapeutics, Inc. Common Stock position peaked at $2.42M in Q2 2015.
  • 11 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.